Sparganosis
https://doi.org/10.22627/2072-8107-2024-23-1-44-48
Abstract
The urgency of the problem of sparganosis is due to the widespread prevalence of this disease in the wild, polymorphism of clinical manifestations and the possibility of severe damage to the orbits, central nervous system and internal organs. The purpose and result of the work is to summarize the data available in the literature on the etiology, epidemiology, clinical picture, diagnosis, treatment, and prevention of sparganosis. Conclusion. The causative agents of sparganosis are Spirometra decipiens, Spirometra erinaceieuropaei, Spirometra folium, Spirometra mansoni, and Sparganum proliferum. Allocate non-proliferative (peripheral, cerebral, spinal, ocular, visceral) and proliferative sparganosis. Diagnostics is carried out on the basis of a complex of clinical, instrumental, serological, molecular genetic studies. Surgical treatment is recommended: complete removal of the spargans
About the Authors
S. B. Chuelov
Pirogov Russian National Research Medical University Ministry of Health
Russian Federation
Russian Federation
Chuelov S. B.
Moscow
A. L. Rossina
Pirogov Russian National Research Medical University Ministry of Health
Russian Federation
Russian Federation
Rossina A. L.
Moscow
References
1. Gaevskaya A.V. The world of human parasites. III. Cestodes and cestodoses of food origin. Sevastopol': OOO «Kolorit», 2017:358. (In Russ.).
2. Kuchta R., Kołodziej-Sobocińska M., Brabec J. et al. Sparganosis (Spirometra) in Europe in the Molecular Era. Clin. Infect. Dis. 2021; 72(5:882—890. doi: 10.1093/cid/ciaa1036
3. Kuchta R., Scholz T., Brabec J., Wicht B. Diphyllobothrium, Diplogonoporus, and Spirometra. In: Biology of Foodborne Parasites. Section III. Important Foodborne Helminths. Chapter 17, pp.299—326. Publisher CRC Press, Boca Raton, Florida. Еdited by L. Xiao, U. Ryan Y. Feng, 2015.
4. Database NCBI (National Center for Biotechnology Information)
5. Database UniProt (Universal Protein Resource) (https://www.uniprot.org/taxonomy/)
6. Kikuchi T., Maruyama H. Human proliferative sparganosis update. Parasitol.Int. 2020. 75: 102036. doi: 10.1016/j.parint.2019.102036
7. Garcia L.S. Diagnostic medical parasitology. 5th ed. Washington, D.C.,ASM Press, 2007.
8. Wiwanitkit V. A review of human sparganosis in Thailand. Int. J. Infect. Dis.2005. 9(6): 312—316. doi: 10.1016/j.ijid.2004.08.003
9. Lu G., Shi D.Z., Lu Y.J. et al. Retrospective epidemiological analysis of sparganosis in mainland China from 1959 to 2012. Epidemiol. Infect. 2014. 142(12):2654—2661. doi: 10.1017/S0950268814000144
10. Kim J.G., Ahn C.S., Sohn W.M. et al. Human Sparganosis in Korea. J. Korean Med. Sci. 2018. 33(44):e273. doi:10.3346/jkms.2018.33.e273
11. Muller R. Worms and Human Disease. Second Edition. CABI Publishing, Wallingford, Oxon, UK, 2002.
12. Lescano A.G., Zunt J. Other cestodes: sparganosis, coenurosis and Taenia crassiceps cysticercosis. Handb. Clin. Neurol. 2013; 114:335—345. doi:10.1016/B978-0-444-53490-3.00027-3
13. Zoonoses and communicable diseases common to man and animals: parasitoses. 3rd ed. Washington, D.C.: PAHO, 2003.
14. Cho J.H., Lee K.B., Yong T.S. et al. Subcutaneous and musculoskeletal sparganosis: Imaging characteristics and pathologic correlation. Skeletal Radiol. 2000. 29:402—408. 10.1007/s002560000206
15. Koo M., Kim J.H., Kim J.S. et al. Cases and literature review of breast sparganosis. World J. Surg. 2011. 35(3):573—579. doi: 10.1007/s00268-010-0942-1
16. Song E.J., Sohn Y.M., Ryu K.N. et al. Breast sparganosis and incidentally detected subcutaneous and intramuscular sparganosis at several sites: case report and literature review. Jpn. J. Radiol. 2015. 33(4):225—228. doi: 10.1007/s11604-015-0405-6
17. Xia Q., Yan J. Diagnosis and surgical management of orbital sparganosis. Eye. 2019. 33:1418—1422. doi.org/10.1038/s41433-019-0427-x
18. Saksirisampant W., Eamudomkarn C., Jeon H.K. et al. Ocular Sparganosis: The First Report of Spirometra ranarum in Thailand. Korean J. Parasitol. 2020. — 58(5):577—581. doi: 10.3347/kjp.2020.58.5.577
19. Chang K.H., Chi J.G., Cho S.Y. et al. Cerebral sparganosis: analysis of 34 cases with emphasis on CT features. Neuroradiology. 1992. 34(1):1—8. doi: 10.1007/BF00588423
20. Park J.H., Park Y.S., Kim J.S., Roh S.W. Sparganosis in the lumbar spine: report of two cases and review of the literature. J. Korean Neurosurg. Soc. 2011. 49(4):241—244. doi: 10.3340/jkns.2011.49.4.241
21. Song T., Wang W.S., Zhou B.R. et al. CT and MR characteristics of cerebral sparganosis. AJNR Am. J. Neuroradiol. 2007. 28(9):1700—1705. doi:10.3174/ajnr.A0659
22. Gong C., Liao W., Chineah A. et al. Cerebral sparganosis in children: epidemiological, clinical and MR imaging characteristics. BMC Pediatr. 2012. 12:155. https://doi.org/10.1186/1471-2431-12-155
23. Li Y.X., Ramsahye H., Yin B. et al. Migration: a notable feature of cerebral sparganosis on follow-up MR imaging. AJNR Am. J. Neuroradiol. 2013. 34(2):327—33. doi: 10.3174/ajnr.A3237
24. Jeon H.K., Park H., Lee D. et al. Human Infections with Spirometra decipiens Plerocercoids Identified by Morphologic and Genetic Analyses in Korea. Korean J. Parasitol. 2015. 53(3):299—305. doi:10.3347/kjp.2015.53.3.299
25. Chung Y.B., Kong Y., Yang H.J., Cho S.Y. IgG antibody responses in early experimental sparganosis and IgG subclass responses in human sparganosis. Korean J. Parasitol. 2000. 38(3):145—150. doi:10.3347/kjp.2000.38.3.145
26. Hong D., Xie H., Wan H. et al. Efficacy comparison between long-term highdose praziquantel and surgical therapy for cerebral sparganosis: A multicenter retrospective cohort study. PLoS Negl. Trop. Dis. 2018. 12(10): e0006918. doi:10.1371/journal.pntd.0006918
27. Zhang P., Zou Y., Yu F.X. et al. Follow-up study of high-dose praziquantel therapy for cerebral sparganosis. PLoS Negl. Trop. Dis. 2019. 13(1): e0007018. doi:10.1371/journal.pntd.0007018
Review
For citations:
Chuelov S.B., Rossina A.L. Sparganosis. CHILDREN INFECTIONS. 2024;23(1):44-48. (In Russ.) https://doi.org/10.22627/2072-8107-2024-23-1-44-48
Views:
491
Email this article 